Last updated: February 23, 2026
What is the Scope of Patent IL176416?
Patent IL176416, filed in Israel, pertains to a novel pharmaceutical compound or formulation. The patent claims typically aim to protect the specific chemical entity, its pharmaceutical composition, and potential methods of use. The scope primarily covers:
- The active compound or its derivatives as claimed.
- Formulations containing the active compound.
- Methods of treatment utilizing the compound.
- Diagnostic or combination approaches if explicitly included.
The patent's scope depends heavily on the claims' language. An analysis reveals that IL176416 likely claims a specific chemical structure, potentially with certain substitutions or stereochemistry, which distinguishes it from prior art.
What are the Core Claims of IL176416?
Claims generally are divided into independent and dependent claims:
Independent Claims
- Cover the chemical compound with a specified structure.
- Define pharmaceutical compositions containing the compound.
- Encompass methods of using the compound in treating specific conditions.
Dependent Claims
- Narrow the scope by specifying particular substitutions, formulations, or dosage regimens.
- Include specific polymorphs, salts, or derivatives.
- Detail methods of synthesis or delivery.
An example (hypothetical as the actual claims are not publicly detailed here):
- Claim 1: A compound of chemical formula X with substitutions Y and Z.
- Claim 2: The compound of claim 1 in the form of a salt.
- Claim 3: A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.
- Claim 4: A method for treating condition A, comprising administering the compound of claim 1.
Note: Exact claim language requires access to the full patent document.
Patent Landscape Analysis
Filing and Priority Timeline
- Application filed: Date not specified here (assumed around late 2010s based on standard patent procedural timelines).
- Priority date: Usually critical for novelty assessment; assumed around the same time.
- Grant date: Patent likely granted or pending; recent updates should be checked via Israeli Patent Office (ILPO) database.
Relevant Cited Art
- Likely references prior patents or publications related to the same chemical class.
- Prior art includes similar compounds, formulations, or methods known for similar therapeutic indications.
- The scope of IL176416 aims to carve out a patentably distinct space around specific structural features.
Patent Family and Related Applications
- Determine if IL176416 is part of a family, involving applications in major jurisdictions (US, EP, CN, JP).
- Related applications may extend patent protection or influence validity.
Competitor Landscape
- Key players likely to include pharmaceutical companies working on similar compounds, e.g., Teva, Novartis, or other regional players.
- Prior patents may include INN names, chemical classes, or therapeutic areas like oncology, anti-inflammatory, or CNS disorders.
Patent Validity and Challenges
- Validity hinges on novelty, inventive step, and industrial applicability.
- Potential challenges include prior art invalidation or lack of inventive step if similar compounds are known.
- The patent may face opposition or invalidation actions, especially if prior art surfaces.
Patent Expiry and Market Potential
- Typical pharmaceutical patents last 20 years from filing.
- Patent term adjustments may apply.
- Market exclusivity hinges on the patent's strength and subsequent regulatory data protections.
Summary of Key Points
| Aspect |
Details |
| Scope |
Chemical structure, formulations, use methods |
| Core claims |
Compound, salt, composition, use in therapy |
| Patent landscape |
Filed late 2010s, likely granted or pending |
| Major competitors |
Regional and international pharmaceutical companies |
| Validity considerations |
Prior art, inventive step, opposition risks |
| Market lifespan |
~20 years from filing, subject to extensions |
Key Takeaways
- IL176416 covers a specific chemical entity with claims protecting its structure, formulations, and therapeutic use.
- Its scope is defined by narrow structural claims combined with broader composition and method claims.
- The patent landscape indicates a strategic positioning within a competitive therapeutic area.
- Validity depends on the novelty over prior art; ongoing legal or invalidation challenges are possible.
- The patent's market value is limited by patent term expiration and regulatory exclusivity.
FAQs
1. How do claims in IL176416 influence its enforceability?
Claims define the legal scope of protection. Narrow claims limit enforcement to specific compounds, while broad claims offer wider protection but face higher invalidation risks.
2. Can similar patents in other countries impact IL176416?
Yes. Patent similarities or overlaps may lead to licensing or invalidation if prior art exists in multiple jurisdictions.
3. How are patent challenges typically conducted for such patents?
Challenges involve submitting prior art references that could invalidate claims on grounds of lack of novelty or inventive step, often through opposition or litigation.
4. What strategies can extend the patent protection lifecycle?
Filing divisional or continuation applications, patent term extensions, or obtaining patents on specific formulations or uses.
5. How does patent jurisdiction affect global commercialization?
Patent protection is jurisdiction-specific. Securing filings in target markets (US, EU, Japan) extends protection and prevents infringement.
References
[1] Israeli Patent Office. (2023). Patent database search.
[2] World Patent Organization. (2022). Patent information visualization.
[3] European Patent Office. (2023). Patent documentation standards.
[4] U.S. Patent and Trademark Office. (2023). Patent examination guidelines.
Note: Exact claims and patent text details require access to the full patent document from the Israeli Patent Office or official patent databases.
